Inhibrx Company Insiders

Inhibrx Management Team Effectiveness

The company has return on total asset (ROA) of (0.5746) % which means that it has lost $0.5746 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (20.3105) %, meaning that it created substantial loss on money invested by shareholders. Inhibrx's management efficiency ratios could be used to measure how well Inhibrx manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.82 in 2024. Return On Capital Employed is likely to drop to -0.91 in 2024. At this time, Inhibrx's Net Tangible Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 310.1 M in 2024, whereas Other Current Assets are likely to drop slightly above 24.3 M in 2024. Common Stock Shares Outstanding is likely to drop to about 38.2 M in 2024. Net Loss is likely to rise to about (124.2 M) in 2024

Inhibrx Workforce Comparison

The company has Profit Margin (PM) of 1019.74 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large.

Inhibrx Insider Trading History

Inhibrx Notable Stakeholders

The success or failure of an entity such as Inhibrx often depends on how effective the management is. Inhibrx management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Inhibrx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Inhibrx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Inhibrx's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Inhibrx. Check Inhibrx's Beneish M Score to see the likelihood of Inhibrx's management manipulating its earnings.

When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.